December 2025 in “Egyptian Reviews for Medical and Health Sciences .” More lesions mean more severe alopecia areata.
May 2023 in “Bali Medical Journal” Higher sebum levels are linked to more severe male baldness.
10 citations
,
May 1974 in “American journal of diseases of children” The girl had a rare disorder causing mental and physical symptoms, with weak hair and unclear neurological issues.
March 2022 in “Research Square (Research Square)” A new growth medium doubles Malassezia restricta yield by using artificial sebum.
March 2026 in “Mendeley Data” Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.
January 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib significantly regrows hair in severe alopecia areata patients.
6 citations
,
February 1997 in “International Journal of Dermatology” Kaposi's sarcoma lesions might originate from benign tissue changes.
November 2025 in “Chemistry - An Asian Journal” EISA uses enzymes to create precise nanostructures in cells, offering new ways to design adaptive materials and therapies.
December 2025 in “Journal of health economics and outcomes research” Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.
January 2023 in “JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH” Combining injections with lotion is more effective for hair regrowth in alopecia areata than using the lotion alone.
November 2007 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not available to parse.
January 1989 in “Skin research” The hair regrowth tonic effectively increased hair count and was safe for treating male pattern baldness.
2 citations
,
January 2012 SESA oil is five times more effective and safe for hair and scalp issues than coconut oil.
48 citations
,
July 2023 in “Pediatric Dermatology” Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.
February 2024 in “Journal of Geochemical Exploration” Selenium levels in soil, crops, and human hair in Northwest China are within safe limits.
6 citations
,
March 2024 in “SKIN The Journal of Cutaneous Medicine” Ritlecitinib is effective for long-term treatment of severe alopecia areata.
April 2021 in “Journal of Investigative Dermatology” Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.
June 2024 in “Dinasti International Journal of Education Management And Social Science” Good logistics service quality and customs clearance boost delivery service loyalty.
September 2011 in “대한미용학회지” Dansam-Samultang promotes hair growth and prevents hair loss.
165 citations
,
October 2013 in “Nature Communications” Scientists made working salivary glands in mice using bioengineered cells, which could help treat dry mouth.
Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.
10 citations
,
June 2024 in “Skin Research and Technology” Autologous epidermal cell suspensions speed up healing and reduce complications in skin lesion treatment but have limited impact on cosmetic outcomes.
1 citations
,
July 2024 in “Journal of Cosmetic Dermatology” Low SULT activity in hair follicles leads to better response to oral minoxidil for hair loss.
6 citations
,
January 2012 in “Hair transplant forum international” Best solution for storing hair grafts is saline with ATP at 4 degrees Celsius, but no definitive best method was confirmed.
December 2025 in “SHILAP Revista de lepidopterología” Correcting selenium and zinc levels may help manage hair loss in autoimmune thyroiditis.
4 citations
,
January 2020 25 citations
,
September 2024 in “Cardiovascular Drugs and Therapy” A real-world pharmacovigilance study analyzed data from four databases to assess the safety of GLP1-RAs concerning suicide, hair loss, and aspiration risks. The study found no significant association between GLP1-RAs and these adverse events. However, GLP1-RAs, especially semaglutide and liraglutide, had higher reporting rates for suicidal events compared to other antidiabetic drugs like DPP4is and SGLT2is. They were also the most reported class for hair loss, with semaglutide, liraglutide, and dulaglutide being prominent. Aspiration events were less associated with GLP1-RAs, with sitagliptin and DPP4is having higher reports. The study emphasizes the need for ongoing monitoring and reporting of these adverse events.
1 citations
,
November 2024 in “Journal of Cutaneous Pathology” Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.